Drug intelligence / Profile preview

Na-APR-1 (M74)

Development stage
Phase 1
Lead developer
Sabin Vaccine Institute
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Na-APR-1 (M74) is a recombinant protein vaccine candidate developed by the Sabin Vaccine Institute Product Development Partnership in collaboration with Baylor College of Medicine for the prevention of hookworm infection caused by *Necator americanus*. The vaccine targets the hookworm's aspartic protease-1 (Na-APR-1), a hemoglobinase essential for the parasite's digestion of host blood. The M74 version is a catalytically inactive mutant of the wild-type enzyme, produced in *Nicotiana benthamiana* plants. It is typically formulated with aluminum hydroxide (Alhydrogel) and may be co-administered with the TLR4 agonist adjuvant GLA-AF to enhance immunogenicity and protective efficacy against hookworm-induced anemia.

Other names
Na-APR-1 (M74)/AlhydrogelHuman Hookworm Vaccine candidate
02

Targets

Na-APR-1 (Necator americanus aspartic protease 1)

Beyond the preview

Go deeper on Na-APR-1 (M74).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Na-APR-1 (M74).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call